Multimodal Validation and Disease Stage Dependency of ATTR Cardiomyopathy Red Flags in Patients With LV Thickening

INTRODUCTION: Timely diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) is critical to improving outcomes and remains challenging. Guidelines recommend assessing for red flags (RFs) to facilitate ATTR-CM detection, but their diagnostic validation remains incomplete. This study aimed to multidimensionally validate these RFs in patients with left ventricular thickening (LVT). METHODS: Prospective registry study including all patients with LVT and standardized workup at tertiary amyloidosis center. For validated RFs, "high-risk" (specificity for ATTR-CM>90%) and "low-risk" (false-negative rate<5%) findings were predefined. RESULTS: 425 patients (321 ATTR-CM,104 control group) were included. Heart failure (97%) and polyneuropathies (78%) were among most sensitive clinical findings, while bilateral carpal tunnel syndrome (bCTS) was more specific (80%) but less sensitive (45%). Diverse ECG changes were common, yet mostly unspecific. Marked elevations of NT-proBNP and troponin were most discriminative among non-imaging RFs (Youden's index[YI]:59%). Apical sparing (Apical-to-Basal-strain-ratio≥2.0) was the most effective, stage-independent echocardiographic parameter (YI62%), followed by biatrial enlargement, advanced diastolic dysfunction, and LVGLS impairment (YI48-55%). Normal ECG without conduction disorders history and normal levels of both NT-proBNP and hs-troponin-T constituted "low-risk" findings. Heart failure with concomitant bCTS, peripheral low voltage, right ventricular dysfunction, 5-5-5 sign, restrictive filling pattern and apical sparing with LVGLS impairment represented "high-risk" RFs. Contrary to most non-imaging RFs, most echocardiographic RFs showed association with advancing disease stage (p<0.05). All aforementioned RFs were associated with ATTR-CM independently of age, sex, and LVT-severity (p<0.05). CONCLUSIONS: ATTR-CM is frequently associated with validated RFs that differ in their diagnostic characteristics, which should be considered when evaluating for ATTR-CM.

Authors

Institutions

Publication Details

Journal
ESC Heart Failure
Published
2026-11-12
DOI
https://doi.org/10.1093/eschf/xvag285
Primary Topic
Amyloidosis: Diagnosis, Treatment, Outcomes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Multimodal Validation and Disease Stage Dependency of ATTR Cardiomyopathy Red Flags in Patients With LV Thickening

Nicolas W. Wieder, Bettina Heidecker, Elena Romero Dorta, Christoph Wetz et al.
ESC Heart Failure
Amyloidosis: Diagnosis, Treatment, Outcomes
article

Multimodal Validation and Disease Stage Dependency of ATTR Cardiomyopathy Red Flags in Patients With LV Thickening

Nicolas W. Wieder, Bettina Heidecker, Elena Romero Dorta, Christoph Wetz, Gerhard Hindricks, Sebastian Spethmann, Isabel Mattig, Jan Gröschel, Stefanie Maria Werhahn, Gina Barzen, Paul J Wetzel, Jeanette Schulz‐Menger, Katrin Hahn, Helena F Pernice, Friedrich Koehler, Jasmin Zernikow, Vera von Landenberg-Roberg, Jakub Piwowarski
article en

Abstract

INTRODUCTION: Timely diagnosis of transthyretin amyloid cardiomyopathy (ATTR-CM) is critical to improving outcomes and remains challenging. Guidelines recommend assessing for red flags (RFs) to facilitate ATTR-CM detection, but their diagnostic validation remains incomplete. This study aimed to multidimensionally validate these RFs in patients with left ventricular thickening (LVT). METHODS: Prospective registry study including all patients with LVT and standardized workup at tertiary amyloidosis center. For validated RFs, "high-risk" (specificity for ATTR-CM>90%) and "low-risk" (false-negative rate<5%) findings were predefined. RESULTS: 425 patients (321 ATTR-CM,104 control group) were included. Heart failure (97%) and polyneuropathies (78%) were among most sensitive clinical findings, while bilateral carpal tunnel syndrome (bCTS) was more specific (80%) but less sensitive (45%). Diverse ECG changes were common, yet mostly unspecific. Marked elevations of NT-proBNP and troponin were most discriminative among non-imaging RFs (Youden's index[YI]:59%). Apical sparing (Apical-to-Basal-strain-ratio≥2.0) was the most effective, stage-independent echocardiographic parameter (YI62%), followed by biatrial enlargement, advanced diastolic dysfunction, and LVGLS impairment (YI48-55%). Normal ECG without conduction disorders history and normal levels of both NT-proBNP and hs-troponin-T constituted "low-risk" findings. Heart failure with concomitant bCTS, peripheral low voltage, right ventricular dysfunction, 5-5-5 sign, restrictive filling pattern and apical sparing with LVGLS impairment represented "high-risk" RFs. Contrary to most non-imaging RFs, most echocardiographic RFs showed association with advancing disease stage (p<0.05). All aforementioned RFs were associated with ATTR-CM independently of age, sex, and LVT-severity (p<0.05). CONCLUSIONS: ATTR-CM is frequently associated with validated RFs that differ in their diagnostic characteristics, which should be considered when evaluating for ATTR-CM.

ESC Heart Failure
Humboldt-Universität zu Berlin (DE), Deutsches Herzzentrum der Charité (DE), Amyloidosis Foundation (US), German Centre for Cardiovascular Research (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Freie Universität Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Amyloidosis: Diagnosis, Treatment, Outcomes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon